LorindaChungMD
Rheumatology • Palo Alto, CAAssistant Professor, Medicine - Immunology & Rheumatology, Stanford University Medical Center
Dr. Chung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Palo Alto, CA 94304Phone+1 650-723-4000Fax+1 650-849-1213
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Rheumatology, 2003 - 2006- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2000 - 2003
Ohio State University College of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2001 - 2025
HI State Medical License 2003 - 2003- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients Start of enrollment: 2005 Feb 01
- A Study to Evaluate the Efficacy of an Oral Medication in the Treatment and Prevention of Digital Ulcers in Patients With Systemic Sclerosis (Scleroderma). Start of enrollment: 2008 Jun 01
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
- Join now to see all
Publications & Presentations
PubMed
- Lipodermatosclerosis and Pulmonary Hypertension in Systemic Sclerosis.Srijana Davuluri, Puneet Kapoor, Swarna Nandyala, Shufeng Li, Julia Simard
JAMA Dermatology. 2024-12-01 - 1 citationsCalcinosis in dermatomyositis.Srijana Davuluri, Lorinda Chung, Christian Lood
Current Opinion in Rheumatology. 2024-11-01 - Racial variability in immune responses only partially explains differential systemic sclerosis disease severity.Kamini E Kuchinad, Ji Soo Kim, Adrianne Woods, Gwen Leatherman, Laura Gutierrez-Alamillo
Annals of the Rheumatic Diseases. 2024-10-21
Journal Articles
- Clinical Significance of Autoantibodies in Dermatomyositis and Systemic SclerosisDavid F Fiorentino, Lorinda Chung, ScienceDirect
- The Scleroderma Patient-Centered Intervention Network Cohort: Baseline Clinical Features and Comparison with Other Large Scleroderma CohortsDaniel E Furst, Robert Spiera, Maureen D Mayes, Lorinda Chung, Suzanne Kafaja, Virginia Steen, Shervin Assassi, Monique Hinchcliff, Rheumatology
Press Mentions
Tocilizumab May Improve Lung Function in Early Systemic SclerosisFebruary 17th, 2021
Pregnancy Outcomes Worse with MyopathiesNovember 30th, 2017
Gene Activity Predicts Progression of Autoimmune Disease, Researchers FindDecember 22nd, 2016- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
